MarketIQ Analyst Report for Healthcare Realty Trust Incorporated

16435 N. SCOTTSDALE ROAD #320, SCOTTSDALE, AZ, US
HR

Last Updated: 09 Nov 2024

Executive Summary

Healthcare Realty Trust Incorporated (HR) is a real estate investment trust (REIT) that specializes in healthcare properties. The company has a market capitalization of $6.3 billion and a dividend yield of 0.07%. HR's stock price is currently trading at $17.78, which is below its 52-week high of $18.90.

Company Overview

HR was founded in 1993 and is headquartered in Scottsdale, Arizona. The company owns and operates a portfolio of 1,036 healthcare properties in 47 states. HR's properties are leased to a variety of healthcare providers, including hospitals, medical offices, and ambulatory surgery centers.

Fundamental Analysis

HR's financial performance has been mixed in recent quarters. The company's revenue declined by 0.077% year-over-year in the third quarter of 2023. However, HR's earnings per share (EPS) increased by 0.768% year-over-year in the same period. HR's balance sheet is strong. The company has a low debt-to-equity ratio of 0.38 and a strong cash position. HR also has a track record of paying dividends, and the company has increased its dividend payout in each of the past 10 years.

Technical Analysis

HR's stock price has been trading in a range between $12.29 and $18.90 over the past year. The stock is currently trading near the bottom of this range. HR's technical indicators are mixed. The stock's relative strength index (RSI) is below 50, which indicates that the stock is oversold. However, HR's moving average convergence divergence (MACD) is above 0, which indicates that the stock is in a bullish trend.

Short Term Outlook

HR's stock price is likely to remain range-bound in the short term. The stock's technical indicators are mixed, and the company's financial performance has been mixed in recent quarters. However, HR's strong balance sheet and track record of dividend payments should provide support for the stock price.

Long Term Outlook

HR's long-term outlook is positive. The company's portfolio of healthcare properties is well-positioned to benefit from the aging population and the increasing demand for healthcare services. HR also has a strong management team and a track record of delivering shareholder value.

Analyst Recommendations

The majority of analysts have a "hold" rating on HR's stock. However, two analysts have a "strong buy" rating on the stock and one analyst has a "buy" rating. The average analyst target price for HR's stock is $18.31.